Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide. [electronic resource] by
- Franco, Raúl
- Rodriguez, Juan M
- Elías, Fernanda
- Hernando-Insúa, Andrés
- Fló, Juan
- López, Ricardo
- Nagle, Carlos
- Lago, Néstor
- Zorzopulos, Jorge
- Horn, David L
- Montaner, Alejandro D
Producer: 20141110
In:
Nucleic acid therapeutics vol. 24
Availability: No items available.
|
|
8.
|
Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy. [electronic resource] by
- Zorzopulos, Jorge
- Opal, Steven M
- Hernando-Insúa, Andrés
- Rodriguez, Juan M
- Elías, Fernanda
- Fló, Juan
- López, Ricardo A
- Chasseing, Norma A
- Lux-Lantos, Victoria A
- Coronel, Maria F
- Franco, Raul
- Montaner, Alejandro D
- Horn, David L
Publication details: World journal of stem cells Mar 2017
In:
World journal of stem cells vol. 9
Availability: No items available.
|
|
9.
|
Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells. [electronic resource] by
- Rodriguez, Juan M
- Elias, Fernanda
- Montaner, Alejandro
- Flo, Juan
- Lopez, Ricardo A
- Zorzopulos, Jorge
- Franco, Raul J
- Lenial, Silvina P
- Lopez Salón, Mariella
- Pirpignani, Maria L
- Solimano, Jorge
- Garay, Guy
- Riveros, Dardo
- Fernandez, Jose
- Cacchione, Roberto
- Dupont, Juan
Producer: 20060816
In:
Medicina vol. 66
Availability: No items available.
|